AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

PACIFIC EDGE LTD

0.097

+0.0066.59%

Volume:3.57K

Turnover:317.00

Market Cap:78.76M

PE:-2.83

High:0.097

Open:0.085

Low:0.085

Close:0.091

Loading ...

Overview Company News Filings

Pacific Edge Completes NZ$16M Equity Raise, Exceeding Target; Plans to Launch NZ$5M Share Purchase Plan

MT Newswires Live

NZX Midday Sector Update: Health Technology Soars, Commercial Services Falls

MT Newswires Live

Pacific Edge Seeks to Raise Up to NZ$20 million Via Placement, Share Purchase Plan

MT Newswires Live

Pacific Edge Says Medicare Coverage of its Tests in US Halted

MT Newswires Live

Pacific Edge Says US Agency Proposes Draft Price for Non-Invasive Urine Test, Shares Jump Over 10%

MT Newswires Live

Pacific Edge Says US District Court Lacks Jurisdiction to Conduct Judicial Review

MT Newswires Live

Pacific Edge's Processed Tests at Laboratories Up Nearly 7% in Fiscal Q4; Shares Rise 3%

MT Newswires Live

Pacific Edge's Cxbladder Triage Included as Standard of Care by American Urological Association

MT Newswires Live

ASX Runners of the Week: Wide Open, Pacific, Forbidden Foods & Olympio

The Sydney Morning Herald

Global Penny Stocks To Watch In February 2025

Simply Wall St.

Pacific Edge’s Cxbladder Triage biomarker test recognised as standard of care in AUA guideline update

Why this ASX small cap stock just rocketed 145%

New Zealand Shares Drop Amid Tech Drag; Pacific Edge Climbs 7% on Medicare Extension

MT Newswires Live

Pacific Edge's Cxbladder Medicare Coverage Gets Two-Month Extension; Shares Up 7%

MT Newswires Live

New Zealand Shares Flat, Asian Shares Mixed Amid Tariff Fears; Inflation Steady in Q4 2024

MT Newswires Live

Australian Shares to Open Higher Amid Wall Street Gains; Woodside 2024 Production at Top End of Guidance

MT Newswires Live

Pacific Edge's Laboratory Throughput Up 0.7% in Fiscal Q3; US Injunction Mulled in Wake of Novitas Decision

MT Newswires Live

New Zealand Shares Fall as Upbeat US Jobs Report Weighs on Rate Cut Bets; Pacific Edge Crashes 55% on Medicare Decision

MT Newswires Live

Pacific Edge Plunges to All-Time Low as Confirms US Medicare Exclusion

MT Newswires Live

ASX Market Open: Sharp Oz downturn after Wall Street bucks on ‘surprising’ jobs data | Jan 13, 2025

The Market Herald

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PEB.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PEB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PEB.AU\",,,,,undefined,":{"symbol":"PEB.AU","market":"AU","secType":"STK","nameCN":"PACIFIC EDGE LTD","latestPrice":0.097,"timestamp":1749190320000,"preClose":0.091,"halted":0,"volume":3573,"delay":0,"nameEN":"PACIFIC EDGE LTD","floatShares":726160840,"shares":811915974,"eps":-0.03427086541422852,"marketStatus":"Market Closed","change":0.006,"latestTime":"06-06 16:12:00 AEST","open":0.085,"high":0.097,"low":0.085,"amount":317,"amplitude":0.131868,"askPrice":0.098,"askSize":744,"bidPrice":0.085,"bidSize":2500,"shortable":3,"etf":0,"ttmEps":-0.03427086541422852,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1749513600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.091,"openAndCloseTimeList":[[1749168000000,1749189600000]],"volumeRatio":0.24492397831165474,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PEB.AU\",,,,,undefined,":{"symbol":"PEB.AU","floatShares":726160840,"roa":"-38.79%","roe":"-74.18%","lyrEps":-0.034271,"volumeRatio":0.24492397831165474,"shares":811915974,"dividePrice":0,"high":0.097,"amplitude":0.131868,"preClose":0.091,"low":0.085,"week52Low":0.05,"pbRate":"3.26","psRate":"3.74","week52High":0.18,"institutionHeld":0,"latestPrice":0.097,"committee":0.541307,"eps":-0.03427086541422852,"divideRate":0,"volume":3573,"delay":0,"ttmEps":-0.03427086541422852,"open":0.085,"prevYearClose":0.135,"prevWeekClose":0.075,"prevMonthClose":0.075,"prevQuarterClose":0.11,"fiveDayClose":0.075,"twentyDayClose":0.08,"sixtyDayClose":0.1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PEB.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2540674198","title":"Pacific Edge Completes NZ$16M Equity Raise, Exceeding Target; Plans to Launch NZ$5M Share Purchase Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2540674198","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540674198?lang=en_us&edition=fundamental","pubTime":"2025-06-03 13:19","pubTimestamp":1748927968,"startTime":"0","endTime":"0","summary":"Pacific Edge  raised NZ$16 million through a share placement, NZ$1 million above its target, and is now preparing to launch a NZ$5 million share purchase plan  for retail investors to support growth initiatives and efforts to restore Medicare coverage, according to a Tuesday filing with the New Zealand and Australian bourses.The placement was strongly supported by existing shareholders and is now awaiting shareholder approval. Meanwhile, the company plans to launch a NZ$5 million SPP for eligible retail investors at the same offer price of NZ$0.10 per share, with the option to accept oversubscriptions, scheduled for late July or early August, the filing said.The capital raise aims to provide Pacific Edge with additional resources and capacity needed to leverage recent clinical and commercial achievements, expand in non-Medicare markets, and restore Medicare coverage for its diagnostic tests, the filing added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EQR","PEB.AU","BK8033","BK4215","BK4585","BK4588","BK7067","PEB.NZ"],"gpt_icon":0},{"id":"2540871776","title":"NZX Midday Sector Update: Health Technology Soars, Commercial Services Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2540871776","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540871776?lang=en_us&edition=fundamental","pubTime":"2025-06-03 09:43","pubTimestamp":1748914984,"startTime":"0","endTime":"0","summary":"Health technology shares gained the most on the New Zealand Exchange, rising nearly 2% by midday Tuesday.Pacific Edge's (NZE:PEB, ASX:PEB) shares rose 15% in recent trade.Meanwhile, commercial services shares fell nearly 3%.PGG Wrightson (NZE:PGW) drove the decline, falling 5% in recent trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NZX.NZ","NZ50G.NZ","NZ20C.NZ","T10G.NZ","PEB.AU","BK8020","BK7067"],"gpt_icon":0},{"id":"2540875436","title":"Pacific Edge Seeks to Raise Up to NZ$20 million Via Placement, Share Purchase Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2540875436","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540875436?lang=en_us&edition=fundamental","pubTime":"2025-06-02 11:37","pubTimestamp":1748835455,"startTime":"0","endTime":"0","summary":"Pacific Edge  said it seeks to raise about NZ$20 million through a share placement and share purchase plan, according to a Friday filing with the New Zealand and Australian bourses.The offer comprises a NZ$15 million placement of new ordinary shares to selected investors and a NZ$5 million retail offer via a share purchase plan, with Pacific Edge reserving the right to accept oversubscriptions in both components at its discretion, the filing said.The shares are priced at NZ$0.10 each, representing a premium to the 20-day volume-weighted average price.The capital raise aims to strengthen Pacific Edge's cash reserves to build on recent clinical and commercial milestones, expand in non-Medicare channels, and work toward restoring Medicare coverage that ceased on April 24 following the implementation of the Local Coverage Determination for Genetic testing for Oncology, the filing added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PEB.AU","BK7067","PEB.NZ"],"gpt_icon":0},{"id":"2531413221","title":"Pacific Edge Says Medicare Coverage of its Tests in US Halted","url":"https://stock-news.laohu8.com/highlight/detail?id=2531413221","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531413221?lang=en_us&edition=fundamental","pubTime":"2025-04-29 14:56","pubTimestamp":1745909762,"startTime":"0","endTime":"0","summary":"Pacific Edge (ASX:PEB, NZE:PEB) noted that the \"Genetic Testing in Oncology: Specific Tests\" local coverage determination became effective on April 24 in the US, halting Medicare coverage of its Cxbla","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PEB.AU","BK8033","BK7067","PEB.NZ"],"gpt_icon":0},{"id":"2531221113","title":"Pacific Edge Says US Agency Proposes Draft Price for Non-Invasive Urine Test, Shares Jump Over 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531221113","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531221113?lang=en_us&edition=fundamental","pubTime":"2025-04-29 14:51","pubTimestamp":1745909472,"startTime":"0","endTime":"0","summary":"Pacific Edge  said the draft 'Gapfill' prices for Cxbladder Triage Plus, a non-invasive genomic urine test, published by the US Centers for Medicare & Medicaid Services, proposed a draft price for the test of $1,018.44, according to Tuesday's Australian and New Zealand bourse filings.The draft price sets the amount Pacific Edge will be reimbursed for all patients with Medicare and Medicare Advantage insurance in the US, subject to the Medicare Administrative Contractor, Novitas, providing coverage of the test.It is currently listed as non-covered on Novitas' local coverage determination. The price is expected to take effect on Jan. 1, 2026.Pacific Edge expects to submit a reconsideration request for coverage of Triage Plus as soon as the analytical validation and clinical validation studies have been published, per the filing.Its shares soared 10% on market close on the New Zealand bourse.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","PEB.AU","PEB.NZ"],"gpt_icon":0},{"id":"2529695918","title":"Pacific Edge Says US District Court Lacks Jurisdiction to Conduct Judicial Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2529695918","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529695918?lang=en_us&edition=fundamental","pubTime":"2025-04-24 07:57","pubTimestamp":1745452652,"startTime":"0","endTime":"0","summary":"Pacific Edge  said the US District Court for the Middle District of Pennsylvania has ruled it lacks jurisdiction to review a Medicare coverage decision affecting the company's Cxbladder cancer test, according to a Thursday filing with the Australian bourse.The Court determined it could not hear Pacific Edge's complaint against the Local Coverage Determination, the filing said.In January, the company received confirmation that its flagship Cxbladder test would no longer be covered by US Medicare contractor Novitas.If not challenged, the finalized decision would become effective, which means reimbursement of Pacific Edge's Cxbladder tests would end.The ruling prevents the court from considering the scientific or medical merits of the company's claims.Despite acknowledging the strength of the company's arguments, a Judge stated that the court was not empowered to intervene in the matter, the filing added.The company said it has made its case for either retiring the LCD or delaying its imp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PEB.NZ","PEB.AU","BK7067"],"gpt_icon":0},{"id":"2524223604","title":"Pacific Edge's Processed Tests at Laboratories Up Nearly 7% in Fiscal Q4; Shares Rise 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524223604","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524223604?lang=en_us&edition=fundamental","pubTime":"2025-04-04 11:00","pubTimestamp":1743735604,"startTime":"0","endTime":"0","summary":"Pacific Edge  reported a 6.8% increase in tests processed at its laboratories in the fourth quarter of fiscal 2025 compared with the prior three-month period, according to a Friday filing with the Australian and New Zealand bourses.Total laboratory throughput rose to 7,577 tests from 7,092 tests between the third and fourth fiscal quarters.However, total volumes for the full fiscal year ended March declined nearly 12% to 28,894 tests from 32,633 in the prior fiscal year. The decline reflected lower sales force due to the uncertainty over Medicare coverage of Cxbladder, per the filing.Pacific Edge's shares were up 3% in New Zealand and by 4% in Australia in recent Friday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XKO.AU","PEB.AU","BK7067","XAO.AU","XJO.AU","PEB.NZ"],"gpt_icon":0},{"id":"2516578262","title":"Pacific Edge's Cxbladder Triage Included as Standard of Care by American Urological Association","url":"https://stock-news.laohu8.com/highlight/detail?id=2516578262","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516578262?lang=en_us&edition=fundamental","pubTime":"2025-03-03 11:01","pubTimestamp":1740970871,"startTime":"0","endTime":"0","summary":"Pacific Edge  said its product Cxbladder Triage has been included by the American Urological Association as the standard of care in an amendment to its clinical guideline for microhematuria patients, according to a Friday filing with the Australian and New Zealand bourses.The guideline mentions the product as the only urine-based biomarker test that has \"Grade A\" evidence from a randomized controlled trial in support of this recommendation, the filing said.Company shares rose 5% in recent Monday trade in New Zealand and jumped almost 22% in Australia.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SMP","XJO.AU","BK4107","BK4124","BK7067","XKO.AU","PEB.AU","AFG","XAO.AU","BK4117"],"gpt_icon":0},{"id":"2514234218","title":"ASX Runners of the Week: Wide Open, Pacific, Forbidden Foods & Olympio","url":"https://stock-news.laohu8.com/highlight/detail?id=2514234218","media":"The Sydney Morning Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514234218?lang=en_us&edition=fundamental","pubTime":"2025-02-28 17:34","pubTimestamp":1740735240,"startTime":"0","endTime":"0","summary":"The ASX has finished off an uneasy week of trading on further shaky footing, as bank stocks continued to release weak December data and United States consumer sentiment began to sour.Shipping logistics giant WiseTech - which exploded into prominence post COVID-19 lockdowns as global trade routes went into turmoil - endured another week of public lambasting, which saw tens of billions of dollars wiped from its market cap. This week’s pandemonium came at the hands of four board directors, who quit on Monday citing “intractable differences” around founder and former-CEO Richard White’s role at the company.This week’s Bulls N’ Bears ASX Runner of the Week is…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.smh.com.au/business/companies/asx-runners-of-the-week-wide-open-pacific-forbidden-foods-and-olympio-20250228-p5lg22.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smh_stock","symbols":["BK7141","BK7104","WOA.AU","BK7050","XAO.AU","AUA.AU","FFF.AU","BK7117","PEB.AU","XJO.AU","BK7067","BK7003","OLY.AU","XKO.AU"],"gpt_icon":0},{"id":"2514343253","title":"Global Penny Stocks To Watch In February 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2514343253","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514343253?lang=en_us&edition=fundamental","pubTime":"2025-02-28 17:05","pubTimestamp":1740733534,"startTime":"0","endTime":"0","summary":"Global markets have recently faced a turbulent period, with U.S. stocks experiencing declines amid geopolitical tensions and consumer spending concerns, while European indices displayed cautious optimism. Despite these market challenges, certain investment opportunities continue to attract attention, particularly in the realm of penny stocks. Although the term \"penny stocks\" might seem outdated, these typically smaller or newer companies offer unique growth potential when backed by strong financials and solid fundamentals. In this article, we spotlight several penny stocks that could stand out as hidden gems with promising prospects for investors seeking affordable entry points into the market.Click here to see the full list of 5,745 stocks from our Global Penny Stocks screener.Overview: Pacific Edge Limited is a cancer diagnostics company that focuses on researching, developing, and commercializing tools for early cancer detection and management across New Zealand, the United States, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/global-penny-stocks-watch-february-090534347.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7067","PEB.AU"],"gpt_icon":0},{"id":"2514839323","title":"Pacific Edge’s Cxbladder Triage biomarker test recognised as standard of care in AUA guideline update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514839323","media":"Small Caps","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514839323?lang=en_us&edition=fundamental","pubTime":"2025-02-28 10:48","pubTimestamp":1740710893,"startTime":"0","endTime":"0","summary":"New Zealand-based cancer diagnostics company Pacific Edge  has had its Cxbladder Triage test included as a standard of care by the American Urological Association .In a major amendment to the 2020 AUA microhematuria guideline, the AUA panel has incorporated language for the use of urine-based biomarkers for intermediate-risk patients.Most notably, it highlighted Cxbladder Triage as the only urine-based biomarker test with ‘Grade A’ evidence from a randomised controlled trial in support of this recommendation.Pacific Edge chief medical officer Dr Tamer Aboushwareb said the company welcomed the authoritative finding, which reinforces best practice within the urological industry and the adoption of Cxbladder in hematuria evaluation.He said the result paves the way for future Cxbladder products – such as the company’s next-generation Triage Plus test, which is designed for use beyond intermediate-risk hematuria patients – to demonstrate equivalent or better performance than Cxbladder Triag","market":"us","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/02/Pacific-Edge-ASX-PEB-American-Urological-Association-Cxbladder-Triage.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/02/Pacific-Edge-ASX-PEB-American-Urological-Association-Cxbladder-Triage.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/pacific-edge-cxbladder-triage-biomarker-test-standard-care-aua-guideline-update/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["PEB.AU","LCD.AU","BK7067","AUA.AU","BK7003"],"gpt_icon":0},{"id":"2514236387","title":"Why this ASX small cap stock just rocketed 145%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514236387","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514236387?lang=en_us&edition=fundamental","pubTime":"2025-02-28 08:16","pubTimestamp":1740701762,"startTime":"0","endTime":"0","summary":"Pacific Edge Ltd  shares are catching the eye of investors on Friday. In morning trade, the ASX small cap stock was up as much as 145% to 13.5 cents. The cancer diagnostics company's shares have pulled back since then but remain up 100% at the time of writing. Why is the ASX small cap stock rocketing?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/28/why-this-asx-small-cap-stock-just-rocketed-145/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["PEB.AU","MAC","BK4551","LCD.AU","BK7110","BK7067","AUA.AU","MAC.AU","BK4080","BK4231","BK7003"],"gpt_icon":0},{"id":"2506550801","title":"New Zealand Shares Drop Amid Tech Drag; Pacific Edge Climbs 7% on Medicare Extension","url":"https://stock-news.laohu8.com/highlight/detail?id=2506550801","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506550801?lang=en_us&edition=fundamental","pubTime":"2025-01-28 12:50","pubTimestamp":1738039839,"startTime":"0","endTime":"0","summary":"New Zealand shares fell Tuesday as a tech-led decline on Wall Street dragged the benchmark index, while Asian shares were mixed amid Lunar New Year festivities.The S&P/NZX 50 Index was down 0.3%, or 4","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVDU","LU1718418525.SGD","BK4581","NVD3.UK","LU1037948541.HKD","NVDA","PEB.AU","NVD","NZ20C.NZ","NVIW.SI","NVDS.UK","NVDS","IE00B19Z8W00.USD","NVDY","IE00BKDWB100.SGD","LU1548497426.USD","LU1814569148.SGD","NVDD","SKT.AU","BK4533","IE00BMPRXQ63.HKD","LU2357125470.USD","IE0034235303.USD","LU1923622291.USD","LU0476273544.USD","NZ50G.NZ","LU0109391861.USD","LU1261432733.SGD","LU0061474960.USD","NVD2.UK","NVDX","T10G.NZ","LU1244550577.SGD","LU0234570918.USD","IE00BMPRXR70.SGD","LU0320765059.SGD","LU1721428933.USD","2NVD.UK","LU2417539215.USD","LU1852331112.SGD","SG9999014575.USD","LU0154236417.USD","3NVD.UK","LU0788109477.HKD","LU0124676726.USD","SNVD.UK","LU1037948897.HKD","LU1242518931.SGD","LU1791710582.SGD"],"gpt_icon":1},{"id":"2506552364","title":"Pacific Edge's Cxbladder Medicare Coverage Gets Two-Month Extension; Shares Up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506552364","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506552364?lang=en_us&edition=fundamental","pubTime":"2025-01-28 12:00","pubTimestamp":1738036828,"startTime":"0","endTime":"0","summary":"Pacific Edge  said the Medicare coverage for its flagship Cxbladder test has been extended by two months to Thursday, April 24, according to a Monday filing with the New Zealand and Australian bourses.Last Jan. 22, the cancer diagnostics company disclosed plans to seek a preliminary injunction in the US relating to the removal of Cxbladder test from the coverage of Medicare contractor, Novitas.Pacific Edge's shares were up 7% in New Zealand and  10% in Australia.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","XAO.AU","PEB.AU","XKO.AU","XJO.AU"],"gpt_icon":0},{"id":"2505651657","title":"New Zealand Shares Flat, Asian Shares Mixed Amid Tariff Fears; Inflation Steady in Q4 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2505651657","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505651657?lang=en_us&edition=fundamental","pubTime":"2025-01-22 12:40","pubTimestamp":1737520801,"startTime":"0","endTime":"0","summary":"New Zealand shares were subdued on Wednesday while Asian shares were mixed as US President Donald Trump's initial policy agenda continued to unfold.The S&P/NZX 50 Index was little changed at 13,037.14","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NZ20C.NZ","NZ50G.NZ","BK7067","CNU.AU","T10G.NZ","BK7015","PEB.AU"],"gpt_icon":0},{"id":"2505084733","title":"Australian Shares to Open Higher Amid Wall Street Gains; Woodside 2024 Production at Top End of Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2505084733","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505084733?lang=en_us&edition=fundamental","pubTime":"2025-01-22 06:44","pubTimestamp":1737499444,"startTime":"0","endTime":"0","summary":"Australian shares are poised to open higher, tracking gains from Wall Street following US President Donald Trump's first day in office.In macroeconomic news, the Westpac Leading Index is slated for re","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7142","XJO.AU","XKO.AU","PEB.AU","WDS.AU","BK7067","XAO.AU"],"gpt_icon":0},{"id":"2505478035","title":"Pacific Edge's Laboratory Throughput Up 0.7% in Fiscal Q3; US Injunction Mulled in Wake of Novitas Decision","url":"https://stock-news.laohu8.com/highlight/detail?id=2505478035","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505478035?lang=en_us&edition=fundamental","pubTime":"2025-01-22 05:48","pubTimestamp":1737496102,"startTime":"0","endTime":"0","summary":"Pacific Edge  reported total laboratory throughput of 7,092 tests for the fiscal third quarter ended December 2024, a 0.7% rise from the prior three-month period, according to a Wednesday filing with the Australian and New Zealand bourses.Its sales force efficiency metric was flat at 379 tests per sales of a full-time employee. Tests per unique US ordering clinician was up 9.1% to 7.The cancer diagnostics company plans to seek a preliminary injunction in the US relating to the removal of its flagship Cxbladder test from the coverage of Medicare contractor, Novitas.Pacific Edge said this move is \"on the basis of the irreparable harm\" that Novitas' decision would cause its business if efforts to negotiate a withdrawal or revision fail, per the filing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PEB.AU","BK7067"],"gpt_icon":0},{"id":"2503416233","title":"New Zealand Shares Fall as Upbeat US Jobs Report Weighs on Rate Cut Bets; Pacific Edge Crashes 55% on Medicare Decision","url":"https://stock-news.laohu8.com/highlight/detail?id=2503416233","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503416233?lang=en_us&edition=fundamental","pubTime":"2025-01-13 12:38","pubTimestamp":1736743114,"startTime":"0","endTime":"0","summary":"Kiwi shares fell Monday along with Asian equities as the US' better-than-expected jobs report dampened hopes for rate cuts.The S&P/NZX 50 Index fell 0.5%, or 68.65 points, to close at 12,827.33.Asian ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","NZ50G.NZ","T10G.NZ","NZ20C.NZ","PEB.AU"],"gpt_icon":0},{"id":"2503187314","title":"Pacific Edge Plunges to All-Time Low as Confirms US Medicare Exclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=2503187314","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503187314?lang=en_us&edition=fundamental","pubTime":"2025-01-13 09:50","pubTimestamp":1736733043,"startTime":"0","endTime":"0","summary":"Pacific Edge's  Australian and New Zealand shares tumbled to all-time lows after the company received confirmation that its flagship Cxbladder test would no longer be covered by a US Medicare contractor.In a Monday filing with the Australian and New Zealand bourses, the cancer diagnostics company called the decision \"flawed\" and said that Novitas \"continues to misunderstand the current standard of care in evaluating hematuria patients.\"Novitas is the Medicare administrative contractor with jurisdiction for Pacific Edge's US laboratory.The company said work is underway to cut its expense base until it regains reliable Medicare coverage and that it is \"well placed\" to fund the re-coverage process.If not challenged, the finalized decision would become effective 45 days from the date of publishing, which means reimbursement of Pacific Edge's Cxbladder tests would end on Feb. 23.Pacific Edge's shares plunged 54% in Australia and by 55% in New Zealand in recent Monday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PEB.AU","XJO.AU","BK7067","XKO.AU","XAO.AU"],"gpt_icon":0},{"id":"2503927523","title":"ASX Market Open: Sharp Oz downturn after Wall Street bucks on ‘surprising’ jobs data | Jan 13, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503927523","media":"The Market Herald","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503927523?lang=en_us&edition=fundamental","pubTime":"2025-01-13 05:39","pubTimestamp":1736717940,"startTime":"0","endTime":"0","summary":"The Australian market is about to be barraged with a very harsh slide on Wall Street from Friday, where surprising jobs data and falling unemployment figures jolted the January rally into a deep red decline across all sectors.The S&P 500 lost 1.54% last Friday, while the Dow Jones trimmed 1.6%; the U.S. indices are now only up around 0.8% since Donald Trump’s election victory.The ASX 200 futures are now tipping a 71-point drop for the local bourse, to be down around 0.86% at open; a decline compounded by the fact the Aussie dollar is taking a beating.Back home, Star Entertainment Group’s  slow-motion blow-up seems to be stretching into this week with the gov’t warning it won’t help things. The Star collapsing would be the first Oz casino crash since late 1998.The takeover saga around Insignia  rolls on too – while the Brookfield approach reported last week likely never happened, it looks like Bain Capital will now match leading sutor CC Capital’s $2.9 billion bid today.That’s Market Op","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-open-sharp-oz-downturn-after-wall-street-bucks-on-surprising-jobs-data-jan-13-2025-2025-01-13/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7078","PEB.AU","SGR.AU","BK7504","BK7062","IFL.AU","VUL.AU","BK7095","BK7067"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PEB.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PEB.AU\",market:\"AU\",,,undefined,":[]}}